Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLANTIS trial
2015-001676-21Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of apixaban in aortic stenosis (AS) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Primary evaluation criterion. Started Jul 2016; status: completed.
02
Drugs
apixaban
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2015-001676-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001676-21.